A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 1,328,909 shares of JNJ stock, worth $208 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
1,328,909
Previous 1,268,781 4.74%
Holding current value
$208 Million
Previous $185 Million 16.13%
% of portfolio
0.48%
Previous 0.46%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$145.48 - $167.38 $8.75 Million - $10.1 Million
60,128 Added 4.74%
1,328,909 $215 Million
Q2 2024

Jul 16, 2024

BUY
$144.38 - $157.78 $6.7 Million - $7.32 Million
46,401 Added 3.8%
1,268,781 $185 Million
Q1 2024

Apr 15, 2024

BUY
$155.22 - $162.74 $6.14 Million - $6.43 Million
39,541 Added 3.34%
1,222,380 $193 Million
Q4 2023

Jan 30, 2024

BUY
$145.6 - $158.88 $5.07 Million - $5.53 Million
34,805 Added 3.03%
1,182,839 $185 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $157 Million - $176 Million
1,008,176 Added 720.86%
1,148,034 $179 Million
Q2 2023

Jul 21, 2023

BUY
$154.35 - $166.11 $83,349 - $89,699
540 Added 0.39%
139,858 $23.1 Million
Q1 2023

Apr 25, 2023

BUY
$151.05 - $180.26 $8.05 Million - $9.6 Million
53,266 Added 61.9%
139,318 $21.6 Million
Q4 2022

Feb 01, 2023

BUY
$160.2 - $179.79 $11.2 Million - $12.6 Million
69,985 Added 435.58%
86,052 $15.2 Million
Q3 2022

Oct 17, 2022

BUY
$161.33 - $179.52 $1.76 Million - $1.96 Million
10,910 Added 211.56%
16,067 $2.57 Million
Q2 2022

Jul 18, 2022

SELL
$168.19 - $186.01 $1.47 Million - $1.62 Million
-8,711 Reduced 62.81%
5,157 $919,000
Q1 2022

Apr 18, 2022

SELL
$158.14 - $179.59 $142,800 - $162,169
-903 Reduced 6.11%
13,868 $2.45 Million
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $1.49 Million - $1.66 Million
9,574 Added 184.22%
14,771 $2.53 Million
Q3 2021

Nov 03, 2021

SELL
$161.5 - $179.47 $9.47 Million - $10.5 Million
-58,620 Reduced 91.86%
5,197 $861,000
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $7.99 Million - $8.57 Million
50,070 Added 364.22%
63,817 $10.7 Million
Q1 2021

May 12, 2021

BUY
$153.07 - $170.48 $114,802 - $127,859
750 Added 5.77%
13,747 $2.25 Million
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $4.52 Million - $5.19 Million
-32,962 Reduced 71.72%
12,997 $2.08 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $1.39 Million - $1.52 Million
9,873 Added 27.36%
45,959 $6.98 Million
Q2 2020

Oct 13, 2020

BUY
$128.81 - $155.51 $4.65 Million - $5.61 Million
36,086 New
36,086 $5.41 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $5.92 Million - $7.15 Million
-45,996 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$111.14 - $153.99 $308,858 - $427,938
2,779 Added 6.43%
45,996 $6.96 Million
Q4 2019

Feb 05, 2020

BUY
$127.5 - $146.44 $2.29 Million - $2.63 Million
17,940 Added 70.97%
43,217 $6.3 Million
Q3 2019

Nov 06, 2019

SELL
$126.95 - $142.14 $2.31 Million - $2.59 Million
-18,225 Reduced 41.89%
25,277 $3.32 Million
Q2 2019

Aug 02, 2019

BUY
$131.15 - $144.24 $5.71 Million - $6.27 Million
43,502 New
43,502 $5.79 Million
Q1 2019

Apr 30, 2019

SELL
$125.72 - $139.79 $4.28 Million - $4.75 Million
-34,005 Closed
0 $0
Q4 2018

Feb 04, 2019

SELL
$122.84 - $147.84 $648,349 - $780,299
-5,278 Reduced 13.44%
34,005 $4.44 Million
Q3 2018

Nov 02, 2018

SELL
$121.58 - $142.88 $433,675 - $509,652
-3,567 Reduced 8.32%
39,283 $5.4 Million
Q2 2018

Jul 30, 2018

SELL
$119.4 - $131.76 $57,670 - $63,640
-483 Reduced 1.11%
42,850 $5.42 Million
Q1 2018

Apr 26, 2018

BUY
$125.1 - $148.14 $2.81 Million - $3.33 Million
22,446 Added 107.46%
43,333 $5.65 Million
Q4 2017

Jan 19, 2018

SELL
$131.22 - $143.62 $591,670 - $647,582
-4,509 Reduced 17.75%
20,887 $3.04 Million
Q3 2017

Oct 18, 2017

BUY
$129.47 - $135.38 $3.29 Million - $3.44 Million
25,396
25,396 $3.38 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Wealth Enhancement Advisory Services, LLC Portfolio

Follow Wealth Enhancement Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.